30 Day Trial

BARE BONES content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Product / Company Performance

The Orthopaedic Implant Company Launches Intramedullary Femur Nail -

The Orthopaedic Implant Company (OIC) commenced U.S. launch of its Antegrade/Retrograde Intramedullary Femur Nail system (ARFN).

The ARFN Nail is designed to treat femoral midshaft and distal fractures, providing retrograde and antegrade approaches in one design, and uses the same instrumentation as all IM nails from OIC. ARFN represents the second IM nail launched by OIC within 2016.

OIC implants are reported to cost cost 50% to 60% less than the average market price of premium implants. All OIC products are FDA cleared.

Sources: The Orthopaedic Implant Company, ORTHOWORLD Inc.

This article is a Member-only item of content. Members, please log in to read the complete post.
If you are not yet a Member, click here to learn more about purchasing ORTHOWORLD Membership.